RxDoctor Payments Data

Beverly Oliver

Family · Bloomfield, IANPI 1023197704

Payments from drug & device makers

$1,510in general payments, 2019–2025

Across 84 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$165
  • Astellas Pharma US Inc$154
  • AbbVie$116
  • Pfizer$113
  • Bayer$93
  • Amgen$88
  • plus $781 from 19 others

What the payments were for

  • Food & beverage$1,41093%
  • Education$1007%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,510 in reported general payments places this provider in the 85th percentile of 1,268 family providers in Iowa.

See all family providers in Iowa

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban92$39,229
OzempicSemaglutide40$36,521
JardianceEmpagliflozin48$29,399
XareltoRivaroxaban29$24,900
TrulicityDulaglutide15$20,640
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$19,514
FarxigaDapagliflozin Propanediol16$9,565
MyrbetriqMirabegron21$9,347
Divalproex Sodium22$3,390
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog16$2,905
Atorvastatin Calcium262$2,098
Tresiba Flextouch U-100Insulin Degludec17$1,976
Ziprasidone Mesylate12$1,810
Metoprolol Succinate126$1,796
Levothyroxine Sodium226$1,710

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$113$39,22992 claims
Novo NordiskOzempic$46$36,52140 claims
Boehringer IngelheimJardiance$165$29,39948 claims
Johnson & JohnsonXarelto$87$24,90029 claims
Lilly USA, LLCTrulicity$12$20,64015 claims
GSKTrelegy Ellipta$40$19,51426 claims
AstraZenecaFarxiga$82$9,56516 claims
Astellas Pharma US IncMyrbetriq$154$9,34721 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,268 family providers in Iowa.

Other family in Bloomfield

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →